Mallinckrodt stock: buy or sell?
September 20th, 2019
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally.
Should I buy Mallinckrodt stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Mallinckrodt stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Mallinckrodt stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 14 ratings published for MNK stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-9-5||BMO Capital Markets||Outperform||Market Perform|
|2019-7-11||Jefferies Financial Group||Hold||Reduce|
|2019-6-6||Wells Fargo & Co||n/a||Market Perform|
|2019-5-24||JPMorgan Chase & Co.||n/a||Neutral|
|2019-5-22||Jefferies Financial Group||Buy||Hold|
Mallinckrodt stock analysis
After sliding for 4 sessions, Friday Mallinckrodt stayed constant a tight 0.00%, closing at $2.44.
After sliding for 4 days, Friday Mallinckrodt stayed steady a tight 0.00%, closing at $2.44.
After boosting a dazzling 43.33% in a week last week, Mallinckrodt closed this week at $2.44 and plunged a chilling -26.06%.
Since early March, when MNK stock price broke down the 40-weeks moving avarage line, it slid $-22.47 per share (-90.20%). Stocks below the 40-weeks moving average line are usually not recommended for average traders.
Mallinckrodt stock price history
Mallinckrodt IPO was on June 17th, 2013 at $43.20 per share1. Since then, MNK stock sliced a -94.40%, with a yearly average of -15.70%.
1: Adjusted price after possible price splits or reverse-splits.
Mallinckrodt stock historical price chart
MNK stock reached 52-week highs on November at $32.34, and all-time highs 2015-03-23 with a price of 134.26.
Mallinckrodt stock price target is $13.80Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 12 price targets for Mallinckrodt stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-9-9||Stifel Nicolaus||Lowers Target||$20.00||$8.00||-60%|
|2019-8-12||SunTrust Banks||Lowers Target||n/a||$7.00||-|
|2019-7-11||Jefferies Financial Group||Lowers Target||$15.00||$10.00||-33.3%|
|2019-6-6||Wells Fargo & Co||Lowers Target||$25.00||$11.00||-56%|
|2019-6-14||Canaccord Genuity||Lowers Target||$37.00||$22.00||-40.5%|
|2019-5-24||JPMorgan Chase & Co.||Lowers Target||$22.00||$11.00||-50%|
|2019-5-22||Jefferies Financial Group||Downgrades||$25.00||$15.00||-40%|
Financials and fundamental analysis
Earnings date and Earnings per ShareMallinckrodt reported great results for 2018-Q4 on February. Mallinckrodt jumped Earnings per Share (EPS) by 13.00%, beating analysts of $1.93. Mallinckrodt posted $2.18.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a tight move of -0.19% to $3,215.60 M USD. When comparing 2018 vs 2017, in contrast, profit margin (that is, the net income divided by revenues) plummed a -178.42% to -112.17%.
|2013||$2,200 M||-||$58 M2.6%||-|
|2014||$2,540 M||15.47%||$-319.30 M-12.6%||-652.42%|
|2014||$2,540 M||-0.02%||$-318.60 M-12.5%||-0.22%|
|2015||$3,347 M||31.77%||$325 M9.7%||-201.91%|
|2015||$2,920 M||-12.76%||$235 M8.0%||-27.75%|
|2016||$3,381 M||15.78%||$644 M19.0%||174.38%|
|2016||$3,380 M||-0.02%||$489 M14.5%||-24.03%|
|2017||$3,222 M||-4.69%||$2,134 M66.3%||336.48%|
|2018||$3,216 M||-0.19%||$-3,607.00 M-112.2%||-268.99%|
Quarterly financial resultsMallinckrodt posted $1,371.30 million in revenues for 2018-Q4, a 114.27% improvement compared to previous quarter. Reported quarter earnings marked $-3,718.40 million with a profit margin of -271.16%. Profit margin plunged a -288.94% compared to previous quarter when profit margin was 17.78%. When comparing revenues to same quarter last year, Mallinckrodt sales marked a tragic decrease and eased a -6.13%. Looking back to recent quarterly results, Mallinckrodt posted 3 negative quarters in a row.
|2017-Q1||$811 M||-||$28.90 M3.6%||-|
|2017-Q2||$825 M||1.68%||$70.60 M8.6%||144.29%|
|2017-Q3||$794 M||-3.71%||$63.70 M8.0%||-9.77%|
|2017-Q4||$1,461 M||84.02%||$1,608.70 M110.1%||2,425.43%|
|2018-Q1||$573 M||-60.80%||$-18.00 M-3.1%||-101.12%|
|2018-Q2||$632 M||10.32%||$15.60 M2.5%||-186.67%|
|2018-Q3||$640 M||1.31%||$113.80 M17.8%||629.49%|
|2018-Q4||$1,371 M||114.27%||$-3,718.40 M-271.2%||-3,367.49%|
Mallinckrodt ownershipWhen you are planning to invest in a stock, it's worth to check its ownership structure.
Mallinckrodt shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 2.20% of all shares.
Bearish positions for MNK stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$205.0 M||$82.2 B||$343.5 B||$10.8 B||$8.2 B|
|Total shares||84.0 M||8,730.0 M||2,640.0 M||515.9 M||1,090.0 M|
|Float shares||83.1 M||8,710.0 M||2,630.0 M||512.7 M||1,000.0 M|
|- Institutional holdings (%)||113.9%||58.6%||69.2%||86.2%||63.5%|
|- Insider holdings (%)||2.2%||0.2%||0.1%||1.1%||4.0%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, September 20th, 2019|
|Day range||$2.31 - $2.80|
|Average true range||$0.59|
|50d mov avg||$4.86|
|100d mov avg||$7.88|
|200d mov avg||$14.30|
Mallinckrodt performanceTo measure stock performance is always good to compare with competitors or related stocks. For Mallinckrodt, the comparison is made against General Electric, , Mylan, Teva Pharmaceutical Industries and Zogenix.